Cannabis Science & Health
Cannabis “Poisonings” in Children Increased Ninefold After Edibles Were Legalized in Canada, Study Finds
After commercial edibles became legally available in 2019, cannabis-related exposures were seen to be responsible for nearly 10 percent of all ED visits for poisonings in Ontario.
Canadian Patients Now Have Better Access to Psychedelic-assisted Therapy, Following a Federal Amendment
Doctors in Canada can now request psychedelic-assisted therapies for their patients through a new program, following an amendment to Health Canada’s Special Access Program (SAP).
What Is the Best Approach to Psychedelic Therapy? An Interview With Field Trip’s Ronan Levy
Technology Networks spoke to the co-founder of Field Trip Health, a Toronto-based provider of ketamine therapy, on why 2021 was such a significant year for psychedelics.
Awakn’s Ketamine-gambling Disorder Study Expands to Test Whether the Drug Can Also Treat Binge Eating
The company behind the trial has expanded it to include three other behavioral addictions: binge eating disorder, compulsive sexual behavior and internet gaming disorder.
Overcoming the Unique Challenges of Novel Cannabinoids With Chromatography
To discuss the chromatographic challenges posed by novel cannabinoids, Analytical Cannabis recently spoke with Sean Orlowicz, business development manager for food and cannabis at Phenomenex.
This Federally-funded Study Will Test Whether Cannabis Can Treat HIV-related Pain
A group of researchers at the University of Mississippi School of Pharmacy have been awarded a $1.37 million grant to study whether cannabis compounds can treat HIV-related pain.
The Research Revealing the Secrets of Hot Hemp
If environmental factors don't lead to hot hemp, which varieties of hemp should farmers opt for? Analytical Cannabis spoke with Jacob Toth, a graduate student at Cornell University’s College of Agriculture, to find out.
What is qPCR Analysis? And How Does a qPCR Machine Work?
In this article, Technology Networks considers how qPCR works, experimental requirements, data analysis and applications of the technique.
Psilocybin Is Safe to Use in 10mg and 25mg Doses, Study Finds
The researchers came to their conclusion after providing the drug to participants of a controlled trial of psilocybin-mediated therapy.
